QTTB is the official Nasdaq stock ticker symbol for Q32 Bio Inc., a clinical-stage biopharmaceutical company. The company utilizes advanced biological engineering platforms to design novel therapeutics aimed at re-regulating adaptive immune functions and targeting complement system abnormalities. Shares traded under this ticker represent equity ownership in the enterprise as it advances its clinical pipeline through various phases of human clinical evaluation, regulatory designations, and public capital markets.